Kuya logo with gold foil effect.

The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder


Transcranial Magnetic Stimulation (TMS)

TMS therapy is emerging as one of the most revolutionary, non-invasive treatments for depression, anxiety, and other related conditions. TMS sends bursts of electromagnetic waves to targeted brain cells (neurons) in the left prefrontal cortex, which causes the cells to depolarize and regain their ability to fire appropriately. This, rather than masking symptoms, is known to actually treat the root cause of the condition by resetting the individual’s neurology.

About the research

This comprehensive review outlines the major aspects of this novel treatment, going into detail to explain the clinical efficacy of TMS and rTMS (repetitive TMS) in the treatment of depression and related conditions. The three large studies referenced in this review all show consistent results, with significant improvements in depression symptoms during the 4-6 week treatment period.

Treatment protocols and guidelines are also laid out in this review, as this treatment grows in popularity due to its undeniable promise in treating such a widespread and debilitating psychiatric condition. The research concludes that TMS is a safe, effective, non-pharmacological option for a wide range of individuals with major depressive disorder (MDD), whether they are already on prescription drugs or not, and is predicted to be a major component of the improved standard of care for depression.

Read the review